Illumina HiSeq 2000 paired end sequencing; Acquired TET2 mutation-linked clonal hematopoiesis in FPD/AML patient led to the development of pre-leukemic clone resulting independently in T2-ALL and AML-M0.
ENA-FIRST-PUBLIC
2017-07-05
ENA-LAST-UPDATE
2018-11-16